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Abstract
Despite the global burden of sexually transmitted diseases, the immunology of the
female reproductive tract is poorly understood. An understanding of how the
distribution of antigen presenting cells in the tissue and cross talk between cell types
both at the site of antigen uptake and in the draining lymph nodes will be important
for the design of new tools to manipulate local immune responses. The murine
estrous cycle is characterised by large changes in the architecture of the vaginal and
cervical epithelia in response to hormonal changes. Here, I show that the
distribution of APCs in the epithelia of the vagina and cervix is not uniform.
Neutrophils infiltrate the tissue in large numbers during the progesterone high stages
of the murine estrous cycle, but this does not affect DC localisation. The iliac lymph
nodes that drain the reproductive tract are structurally similar to other mucosal
lymph nodes, but DCs are reduced in frequency compared to LNs draining other
sites. RALDH expression, a marker for retinoic acid metabolism was also reduced
in iliac compared to other peripheral lymph nodes. The murine lower female
reproductive tract and its draining lymph nodes are, therefore, distinct from other
mucosal tissues and lymph nodes and warrant further investigation.
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1. Introduction
Sexually transmitted infections (STIs) are a worldwide health problem [1, 2]. In
1999 there were 340 million new cases of STIs worldwide [3]. This equates to a
huge burden of disease. They cause high mortality; AIDS related deaths account for
1.8 million deaths globally per year [4]. STIs can also cause complications such as
infertility and spontaneous abortion and increase risks of developing other diseases;
for example 95% of cervical cancers are associated with previous HPV infection [5].
STIs are a growing problem with rates of new infections going up in the UK [6].
Protective immune responses against STIs may rely on long-lived, effective local
responses in the female reproductive tract (FRT) to prevent infection. However,
these have proven difficult to manipulate, as both systemic and intravaginal
immunization strategies are unreliable at initiating protective immune responses in
the FRT [7, 8]. Despite the need for comprehensive research, immunity in the
female reproductive tract (FRT) remains under-studied.
1.1. Defence of mucosal tissues
The mucosal surfaces of the gastro-intestinal, respiratory and genito-urinary tracts
are the main sites of pathogen entry. They must act as barriers to potential pathogens
[9], but are also populated by harmless, and in some cases beneficial, commensal
organisms [7, 9-11]. Immunity in mucosal tissues must balance prevention of
disease with tempered responses to the vast majority of microorganisms without
disrupting the normal functioning of the mucosal tissues [12]. In mucosal tissues the
majority of antigen elicit tolerogenic responses, which are characterised by
regulatory T cells (Tregs) and anti-inflammatory cytokines such as IL-10 and TGF-β 
[13].
Mucosal tissues facilitate the acquisition of essential nutrients, water and oxygen
from the environment and, therefore, must balance the need to allow passage of
some molecules while preventing the invasion of potential pathogens. To limit
pathogen invasion, mucosal secretions contain a variety of antimicrobial agents. For
example there are antimicrobial peptides in saliva, urine, intestinal fluid [14],
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seminal plasma [15] and cervicovaginal fluid [2, 9, 12, 14]. The stomach produces
acid and the cervicovaginal fluid is also slightly acidic [2, 16]. Mucosal tissues
produce a great deal of mucus [2, 12], which captures organisms. Mechanical
activity, such as the mucociliary escalator in the lung [17], helps to eliminate many
pathogens.
There are many commensal organisms living on mucosal tissues. Some are
beneficial, as in the microbiota of the gastro-intestinal tract [18, 19] and Lactobacilli
[20, 21] in the genitourinary tracts [2]. Commensals may compete with pathogens
for attachment to mucosal surfaces, restricting their colonisation, however the
normal flora is not always beneficial. Candida species, which are normally non-
invasive commensals can cause invasive infections in response to changes in the
vaginal environment brought on by hormonal changes [22].
1.2. Initiation of the immune response
Cells of the immune system can be divided into innate and adaptive immune cells.
Innate phagocytic cells such as macrophages and neutrophils, which engulf and
destroy pathogens, recognise broad categories of pathogen and respond rapidly to
infection. Adaptive cells, such as T and B cells recognise, species or strain specific
protein antigens and tailor the immune response to that particular organism. They
mediate more efficient responses both qualitatively and quantitatively to such an
extent that they can confer life-long systemic protection from re-infection. There are
large numbers of T and B cells, each with different antigen specificities.
At mucosal sites antigen-presenting cells (APCs) survey the local environment for
signs of infection and tissue damage. Many cell types can be APCs including
macrophages, B cells and neutrophils [23-25]. Dendritic cells (DCs) are phagocytic
cells that bridge the gap between the innate and adaptive immune systems. They are
‘professional’ antigen presenting cells that reside within tissues and lymph nodes.
Their primary function is to acquire ‘foreign’ peptide antigen and initiate the
adaptive immune response. They express an array of pathogen recognition receptors
(PRRs), such as Toll-like receptors (TLRs) [26, 27], that have a broad specificity for
highly conserved pathogen associated molecular patterns (PAMPs) [2]. Acquisition
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of antigen and ligation of PRRs results in DC maturation and migration to draining
lymph nodes (dLN) where they present antigen to naïve T cells.
T cells recognise a specific peptide antigens bound to major histocompatibility
complex (MHC) on APCs. APCs express co-stimulatory molecules, such as CD40
which lower the threshold for activation. They also direct the homing of T cells to
different tissues. For example APCs induce T cell homing to mucosal tissues by
production of retinoic acid, which induces the upregulation of mucosal addressins
(discussed further in chapter 5). Finally, APCs produce cytokines that direct T cell
differentiation into functionally different subtypes of effector T cells, which mediate
different types of immune response. After clearance of infection some antigen-
specific memory T cells patrol the mucosal sites and LNs ready to respond to re-
infection [28].
1.3. Effects of the local tissue environment on APCs
There is increasing appreciation within the field of immunology of the role played by
non-haematopoietic cells in all stages of immunity [29-39]. DC maturation is
affected by the local environment. Cytokines, stress molecules and cellular
interactions can all affect DCs [27]. Epithelial cells of the oral mucosa [33], gut [11,
19], FRT [40, 41] and lungs [32, 42], as well as epidermal and endothelial cells [39]
also express PRRs and on ligation of those PRRs they can produce chemokines,
which recruit APCs and other immune cells, and cytokines, that can influence the
maturation of DCs [11, 32, 42]. APCs are also sensitive to molecular markers
produced by damaged epithelial cells, which affect maturation and cell recruitment.
These can be cytokines, chemoattractants, alarmins such as HMGB1 or heat shock
protein which are produced by infected or damaged cells, or intracellular molecules,
which are only found outside cells after necrotic cell death [31, 43]. There are
different stress indicator molecules produced after different severities of epithelial
damage, which bias the immune response in different ways; promoting a regulatory
response after mild damage and an inflammatory response after severe damage [31,
32]. Epithelial cells in the intestine condition DCs and macrophages towards
tolerogenic responses to commensal bacteria in order to maintain gut homeostasis
[11].
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It is important not to view immune responses in terms of interactions among innate
and adaptive immune cells and pathogens on a background of tissue stromal cells,
but to think of the functioning of the organ and its resident stromal cells and how it
recognises pathogens, recruits and directs immune cells and resolves infection while
retaining its normal functioning. If the small intestine is infected the main event is
not the immune response to the infection, but the continuing absorption of food. It is
therefore important to understand the immune response in the context of the tissue it
occurs within.
1.4. Characteristics of mucosal immune responses
The majority of antigen that enters the body through mucosal surfaces induces a
tolerance response. This has been best characterised by the immunosuppressive and
anergic responses to orally administered antigen - so called oral tolerance [44]. The
antibody response at mucosal surfaces is usually dominated by IgA [13] with lower
levels of IgG and IgE [7]. The predominant antibody in serum is IgG [8]. In the
small intestine B cells switch to IgA production in the Peyer’s patches (PPs) under
the influence of TGF-β and IL-10 [13].   
T cells primed in the small intestine express distinct mucosal addressins and
chemokine receptors, which allow them to traffic to the intestinal mucosa. T cells
from the MLNs upregulate α4β7 integrin, which binds MAdCAM-1 expressed on
mucosal vasculature. T and B cells express CCR9, which binds CCL25 expressed
by intestinal epithelial cells [7, 13].
In PPs and MLNs there are distinct phenotypes of DCs. There are unusually large
numbers of CD8α-CD11b- DCs and lower percentages of CD8α-CD11b+ DCs
compared to the spleen where the majority of DCs are CD8α-CD11b+ [13].  CD8α-
CD11b+ DCs in the PPs preferentially produce IL-10 compared to splenic CD8α-
CD11b+ DCs, which produce IL-12 under the same conditions. DCs in the MLNs
produce IL-10 and TGF-β in response to oral antigen and promote upregulation of 
α4β7 on T cells [13].
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1.5. Challenges of studying immunology in the FRT
The tissue of the lower FRT consists of layers of squamous epithelial cells, similar to
skin, with connective tissue underneath (Fig 1.1) [28, 45]. The epithelia are covered
in mucus. In humans the epithelia is non-keratinized, but in mice the outer layers
become keratinized [45, 46].
The FRT is a unique mucosal environment. The FRT undergoes homeostatic
remodelling in response to sex hormones in mammalian reproductive cycles, which
results in dramatic cyclic changes in the epithelia and lamina propria of the uterus,
cervix and vagina. The FRT must prevent infection while at the same time
promoting conception and gestation of the genotypically different foetus. This
presents a challenge for the immune system. The issue of balancing the
reproductive function against protection from disease is particularly problematic
after ovulation. The FRT must become permissive to sperm to increase the chance
of fertilization, but sexual intercourse is also when the female is at highest risk of
infection by sexually transmitted pathogens. The environment of the vagina changes
to allow insemination. It becomes less acidic, the mucus becomes less thick and
more permissive [47].
Unlike other mucosal sites, the FRT tissue and the tissue resident immune cells are
similar to those of the skin. There are Langerhans’ cells (LCs) in the epithelia with a
separate DC population in the lamina propria. As has been shown in the skin [48,
49], different DC subtypes have different roles in immunity [50]. Submucosal DCs
rather than the LCs, migrate to the draining lymph nodes and present antigen to T
cells [50]. The humoural immune response in the FRT is different to other mucosal
surfaces. Like the gut, the FRT has IgA in secretions; however unlike the gut there
are much higher levels of IgG in cervicovaginal secretions [8, 40, 51-54]. IgG in
cervicovaginal secretions is produced locally by antigen secreting cells and comes
from the blood [8, 40, 51-54].
There is some evidence that hormones and their effects on stromal and epithelial
cells in the FRT can affect immune responses [40, 55-60] through changes in PRR
expression [61], cell recruitment, antibody levels, antigen presentation[40, 55, 58,
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59, 62], T cell responses and susceptibility to STDs [58-60] over the estrous cycle or
after hormone treatment (discussed further in chapter 4).
Like in the intestinal mucosa, the FRT can induce tolerance [63], but it appears to be
estrous cycle stage specific. There was no difference in antigen-trafficking to the
draining lymph nodes or in the serum antibody response at different cycle stages, but
spleen and lymph node cells also showed significantly less proliferation in response
to restimulation after priming in estrus [63].
1.6. Aims
Relative to other mucosal sites little is known about the immunology of the genital
tract. The changeable conditions in the FRT pose a challenge to experimental
design. Rats & mice have different reproductive cycles to humans and therefore
questions remain about their suitability for translational research.
The aim of this study was to characterise the murine FRT in steady state to identify
some of the factors which affect the initiation of the immune response to antigen.
Specifically;
i. To use immunohistochemistry to characterise the FRT at different stages of
the cycle.
ii. To examine the distribution of antigen presenting cells in the vagina and
cervix
iii. To compare the FRT dLNs (iliac LNs) to other mucosal/non-mucosal LNs to
try to identify factors, which may affect antigen presentation and the
downstream adaptive immune response.
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Figure 1.1: The human female reproductive tract.
The FRT can be split into two: The lower FRT, consisting of the vagina and
ectocervix and the upper FRT consisting of the endocervix, uterus and ovaries. The
lower FRT is covered in layers of squamous epithelial cells, while the upper FRT is
covered in a simple columnar epithelial layer. Figure from [45].
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2. Materials and Methods
2.1. Mice
6-10 week old female C57BL/6 (B6) or B6.CD45.1 mice (Charles River UK) were
housed under specific-pathogen free conditions Mice were kept in a continuous 12
hour light/dark cycle and were caged only with females from weaning. 8 week old
female CD19CreR26REYFPVaDsRedxC57xC57 mice were bred under specific-
pathogen free conditions. All procedures were done in compliance with the Animal
(Scientific Procedures) Act 1986.
2.2. Depo-Provera treatment and vaginal smears
Mice were injected subcutaneously in the base of the tail with 100 µl of 30 mg/ml
Depo-ProveraTM (Pharmacia) in sterile saline (Baxters, UK) 5 days prior to use.
Vaginal smears were taken using a pipette and approximately 30-50 µl sterile saline
then placed on polylysine slides (Fisher) with or without further dilution, depending
on viscosity of the mucus. Slides were air dried then haematoxylin and eosin (H&E)
stained.
2.3. Serial sectioning of the FRT
Reproductive tracts from mice were divided into lower vagina, upper vagina, and
cervix and snap frozen in OCT embedding medium (TissueTek) in plastic
Cryomolds (TissueTek) and stored at -80°C.  Transverse 7 μm serial sections from 
the lower vagina, upper vagina and cervix were cut on a cryostat and placed on
polylysine slides (Fisher). Approximately 6 slides (approx. 48 tissue sections) were
prepared sequentially. 60-100 µm of tissue was removed before another 6 slides
were prepared to allow representative sampling of the whole lower FRT. Slides
were air-dried then stored at -20°C ready for H&E staining or
immunohistochemistry.
2.4. Haematoxylin and eosin staining
Air-dried slides were stained in Harris haematoxylin (Sigma) for 5 minutes and then
washed in cold running water for 5 minutes. Slides were dipped 12 times in 0.5%
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eosin then dipped in distilled water. Slides were then dipped 10 times in 50%
ethanol, 10 times in 75% ethanol, left in 95% ethanol for 30 seconds followed by 1
minute in 100% ethanol. Slides were air dried then mounted in DePex (VWR BHD
Prolabo) with a cover slip. Images were acquired on Zeiss Axioplan microscope
using an Optronics camera and brightness and contrast were adjusted using
Photoshop, as required.
2.5. Immunohistochemistry
Sections were fixed in ice cold acetone for 5 minutes, washed in PBS 0.05% BSA
(Fisher) and then blocked in PBS 0.05% BSA containing 5% Rat (Sigma), or
Hamster (MP Biomedicals) serum or blocking IgG for at least 1 hour. An avidin-
biotin blocking kit (Invitrogen) was used according to the instructions, when
biotinylated antibodies were used.  Briefly, sections were blocked with β-biotin (10 
min), washed (PBS 0.05%BSA) and then incubated with avidin (10 minutes)
followed by 3 washes. Slides were then stained with CD11c, CD68 or Gr-1
antibodies (see table) or appropriate isotype controls in blocking buffer for 45
minutes. Slides were washed as above. For experiments using biotinylated
antibodies Streptavidin-AlexaFluor546 or Streptavidin-AlexaFluor488 (both
eBioscience) diluted 1:300 in blocking buffer was then added and incubated at room
temperature for 30 minutes. The slides were then washed 3 times as above and then
once in PBS. Slides were counterstained with 1 mg/ml DAPI, for 5 minutes, if
required, washed in PBS twice and then mounted in Prolong Gold anti-fade reagent
(Fisher) with a cover slip. Images were captured using a Zeiss inverted 510 Meta on
Axiovert 200M confocal microscope and analysed using Zeiss LSM Image Browser
software and cells were counted using ImageJ software. Stitched images of LNs
were made using Fiji software.
Antibody Fluorochrome Isotype control Dilution Supplier
CD11c Alexafluor 647 Hamster IgG 1:200 eBioscience
CD68 Alexafluor 647 Rat IgG2a 1:100 eBioscience
MHCII biotinylated Rat IgG2b 1:200 eBioscience
MHCII Alexafluor 450 Rat IgG2b 1:200 eBioscience
GR-1 biotinylated Rat IgG2b 1:200 eBioscience
gp38 Alexafluor 488 Hamster IgG 1:200 eBioscience
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CD31 biotinylated Rat IgG2a 1:200 eBioscience
Table 2.1 Antibodies used for immunohistochemistry
2.6. Quantification of immunohistochemically stained tissue
sections
2.6.1. Pixel counts
For each field of view lines were drawn around the epithelia using Photoshop. The
epithelia were selected and the total pixel counts performed. The green, red and
yellow channels were selected in turn and pixel counts performed for each. The
pixel count for one channel was divided by the total pixels (x100) to give a
percentage. For the total CD11c or MHCII cells the red and green channels
respectively were added to the yellow channel and expressed as a percentage of total
pixels.
2.6.2. Cell counts
The lengths of the basal layers of the epithelia were measured using LSM software.
The number of cells in the epithelia were counted using ImageJ software and the
results were expressed as cells/mm.
2.6.3. Determining neutrophil density
Blind analysis was done using LSM software. Images showing only GR-1+ and
DAPI staining were designated as high or low neutrophil areas. Greater than 50% of
the outer epithelial length positive for Gr-1 was designated as neutrophil high.
Images showing only CD11c+ and DAPI staining channels were used for DC counts.
2.7. Stereo imaging of CD19CreR26REYFPxC57BL/6xC57BL/6
mice
Single images of mice were taken under white, red fluorescent and green fluorescent
light in turn on a stereo microscope (Zeiss) and captured using a CCD camera.
Individual images were overlaid in ImageJ.
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2.8. Isolation of lymph node cells and surface staining for flow
cytometry
Lymph nodes from multiple mice were pooled into groups of cervical lymph nodes,
iliac lymph nodes, mesenteric lymph nodes and a group of ‘other’ lymph nodes,
which included axillary and inguinal lymph nodes. Pooled LNs were diced into
small pieces with a scalpel and forceps then washed in PBS. These were incubated
for 25 minutes at 37°C in 1 ml of enzyme mix containing 1.8 Wünsch units/ml
Liberase TL (Roche) and 0.5 mg/ml DNaseI (Roche) in PBS. The resulting digests
were then passed through a 70 µm cell strainer (BD Biosciences). Cells were
washed (1300 rpm for 5 minutes) twice in PBS 1% FCS. Viable cell counts were
determined by Trypan blue exclusion using a haemocytometer. Pooled cells from
lymph nodes were blocked in Fc block (eBioscience 0.5 µg/ml) in PBS 1% FCS for
15 minutes on ice. Cells were washed in PBS 1% FCS as above then split into 2x106
per sample. Cells were stained for CD11c, MHCII, CD11b, CD103 and CD45.2 or
with appropriate isotype controls (See table 2.2) and incubated on ice, covered in foil
to protect from light for 25 minutes. Cells were washed twice in PBS 1% FCS as
above. Cells were fixed in 4% PFA for 20 mins on ice and were stored at 4°C until
analysis. Samples were analysed on a CyAn flow cytometer using Summit software
(Beckman Coulter).
Antibody Fluorochrome Isotype
control
Dilution Supplier
CD11c PE-Cy7 Hamster IgG 1:400 eBioscience
MHCII e450 Rat IgG2b 1:400 eBioscience
MHCII APC-Cy7 Rat IgG2b 1:400 eBioscience
CD45.2 APC-780 Rat IgG2a 1:200 eBioscience
CD11b e450 Rat I gG2b 1:200 eBioscience
CD103 PE Rat IgG2a 1:200 eBioscience
Table 2.2 Antibodies used for flow cytometry staining
2.9. ALDEFLOUR staining
To identify cells containing active RALDH enzyme activity, ALDEFLUOR reagents
(Stemcell Technologies) were used. Cells were stained for surface markers as above
but without fixation. After surface staining, cells were washed in PBS 1% FCS as
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above then resuspended in 50 µl ALDEFLUOR assay buffer. 50 µl ALDEFLUOR
substrate or DEAB inhibitor diluted 1:15 in ALDEFLUOR substrate were added to
appropriate wells and incubated in foil at 37°C 5% CO2 for 30 minutes. Samples
were washed in ALDEFLUOR buffer then resuspended in PBS. 1 µl of
LIVE/DEAD Fixable aqua dead cell stain (Invitrogen) was added to each sample
then incubated on ice for 30 minutes in foil. Samples were washed in PBS then
resuspended in PBS 1% FCS before analysis on a CyAn flow cytometer using
Summit software (Beckman Coulter).
2.10. Statistical Analysis
Statistical analysis was performed using GraphPad InStat 3 software. Nonparametric
Mann-Witney-tests were used for all analysis.
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3. Histological characterisation of the lower FRT over the
murine estrous cycle
3.1. Introduction
Mice are the common model for immunology and infection research because they
are a relatively cheap and easy to use mammalian species that are genetically similar
to humans and other mammals. They also have the advantage of the huge range of
genetically defined or altered mouse strains available. These allow researchers to
design experiments that assess the role of specific genes, which could not be done in
humans. Research in mouse models is often used to draw conclusions about human
immunology, so it is important to have a thorough understanding of the similarities
and differences between them and what this could mean for the application of mouse
research to human research. Importantly, humans and mice have different
reproductive biology. Human females of reproductive age, not receiving hormonal
contraception have a menstrual cycle which lasts around 28 days. It is characterised
by a period of endometrial growth, known as the follicular phase, followed by
ovulation. This is followed by the luteal or secretory phase, where the ovaries
produce large amounts of hormones that facilitate implantation and early growth of
the fertilised ovum. If fertilisation does not occur the ovum degenerates and
menstruation occurs, in which the endometrium is sloughed off and is expelled from
the body [16]. Conversely, mice and rats have estrous cycles. The main difference
between mammalian menstrual and estrous cycles is that in the menstrual cycle the
epithelial cells shed into the lumen are discharged out of the vagina, whereas in the
estrous cycle the epithelial cells are broken down and reabsorbed [16].
Mice have non-seasonal polyestrous cycles and spontaneously ovulate [16, 64],
which means that, similar to humans, they ovulate multiple times throughout the
year at regular intervals and do not require sexual stimulation to ovulate. Unlike
many other estrous animals such as sheep and dogs, the murine estrous cycle is not
driven by seasonal cues and mice will not naturally enter a anestrus stage in which
the animal is unable to reproduce [16].
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The murine estrous cycle lasts 4 to 5 days [64] and ovulation occurs spontaneously
whether mating has occurred or not [64]. It comprises a period of preparing the
tissue for nourishing a fertilised egg, before a period of ‘heat’ where the animal is
receptive to mating and ovulation occurs. If fertilisation does not occur the
reproductive tract undergoes a period of shedding before restarting the cycle. The
estrous cycle can be split into 4 stages; proestrus in which the ovarian follicles grow
and the uterine epithelium thickens, estrus in which ovulation occurs, metestrus
begins when the uterine epithelium sheds and diestrus when the epithelia is at its
thinnest before the cycle restarts [64, 65]. Metestrus and diestrus are sometimes
referred to as metestrus-1 and -2 or diestrus-1 and -2 [64], however, in this study the
metestrus will be used to refer to the stage immediately after estrous followed by
diestrus. Proestrus and estrus are equivalent to the follicular phase of the human
menstrual cycle and metestrus and diestrus are similar to the luteal phase.
Events in the ovaries are almost identical in the estrous and menstrual cycles and the
kinetics of luteinising hormone (LH) and follicle-stimulating hormone (FSH) levels
in the blood stream follow almost identical patterns [16, 64, 66]. FSH produced in
the pituitary promotes maturation of the ovarian follicle. LH causes the maturing
follicle to produce estrogen, which results in increased LH production through a
positive feedback loop. Rising LH causes ovulation [64]. The ovarian follicle then
becomes a corpus luteum and secretes hormones that promote survival and growth of
the fertilised ovum. The corpus luteum degenerates and the decreasing hormone
concentrations causes epithelial shedding in the uterus [16, 64].
The vaginal epithelium consists of stratified squamous epithelium [2, 16, 41], similar
to skin. The stromal and epithelial cells are under hormonal control. The epithelial
architecture of the uterus, cervix and vagina changes in response to estrogen and
progesterone (Fig3.1). Increased estrogen leads to thickening of the epithelia and
ovulation, while high progesterone is associated with thinning of the epithelia.
Much of the hormone-induced changes in the vaginal tissue are mediated by the
stromal cells in the lamina propria, which control epithelial cell behaviour and
immune cells.
Characterisation of antigen-presenting cells in the murine female reproductive tract
and its draining lymph nodes
15
3.2. Results
The histology of the FRT over the estrous cycle has been well characterised in rats
[67], but less so in mice. In order to assess the physiological changes in the FRT 6-8
week old female mice were vaginally smeared and these smears were H&E stained
and used to classify each mouse into an estrous cycle stage. C57BL/6 CD45.2 or
C57BL/6 CD45.1 mice were used because they are common laboratory mouse
strains. They differ in the allelic form of CD45, which results in no functional
differences. The two strains are, otherwise, assumed to be identical. The FRTs
were removed and snap frozen in order to preserve the tissue architecture. To
characterise the tissue throughout the tract serial transverse tissue sections of the
vagina and cervix were H&E stained (Fig 3.2).
3.2.1. Vaginal Smears
The histology of vaginal smears can be used as a predictor of estrous cycle stage, as
has been shown in rats [68]. To establish a protocol based on the murine estrous
cycle individual mice were smeared everyday for 4 days+ at approximately the same
time every day. H&E stained vaginal smears were assigned into one of the 4 estrous
cycle stages based on guidelines for the reading of rat vaginal smears [68]. Smears
were also taken from high-dose progesterone (Depo-Provera) treated mice at 5 days
post treatment and on some occasions at 6 – 30 days post treatment. The vaginal
smear classification scheme devised is summarised in table 3.1.
In proestrus (Fig 3.3A) the smears contained few cells and were made up almost
exclusively of epithelial cells. The smears contained differing ratios of small,
rounded, nucleated epithelial cells with pale cytoplasm and larger, cornified cells,
which appear pinker, probably due to keratinisation and increased glycogen.
At estrus there were huge numbers of large non-nucleated cornified epithelial cells in
the smear (Fig3.3B). The cornified cells were large, flattened, highly eosinophilic
and clumped together. Other cells were almost completely absent in the smear.
At metestrus the predominant cells in the wash were leukocytes (Fig3.3C). The
majority of leukocytes were polymorphonuclear neutrophils, which can be identified
by their multi-lobed nuclei (open arrows). The smears were generally thick with
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mucus, causing leukocytes and non-nucleated cornified epithelial cells to clump
together. In some smears the epithelial cells are nearly all large anucleated cornified
cells, but in others more nucleated cells were present in the smear.
At diestrus the majority of cells in the smear were leukocytes with some cornified
and/or nucleated epithelial cells (Fig3.3D). Leukocytes were less clumped in
diestrus compared to metestrus smears, though there was considerable variation.
After Depo-Provera treatment the smears were similar to the smears from
metestrus/diestrus. The majority of cells were leukocytes with smaller numbers of
nucleated epithelial cells (Fig3.3E). There was a large amount of thick mucus
present in the smears which caused clumping of cells; however this did vary from
mouse to mouse.
Table 3.1: Determining estrous cycle stage using vaginal washes.
3.2.2. Histology at proestrus
The vaginal lumen was devoid of cells in the tissue sections, consistent with the
smears which contained few cells (Fig 3.4A). The epithelium was thick at proestrus
and was densely packed with very few visible gaps between epithelial cells. The
epithelium varied in thickness from approximately 5-25 cells thick (Fig 3.4B&C). In
most sections the outermost layer of the epithelium was anucleated, but not
keratinised (Fig 3.4B), but in some there was a highly eosinophilic band in the outer
epithelium showing keratinisation of the outer epithelium into the stratum corneum
(SC) (Fig 3.4C).
Proestrus Estrus Metestrus Diestrus Depo-
Provera
Nucleated epithelial
cells
+ - - + +
Non-nucleated
epithelial cells
- +++ ++ - -
Leukocytes - - +++ ++ ++
Mucus + ++ +++ ++ +++
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3.2.3. Histology at estrus
Strings of cornified epithelial cell sheets were seen filling the lumen in tissue
sections (Fig 3.5A). Some areas of the epithelium were relatively thick while others
were comparatively thin. In most sections the stratum corneum was partly detached,
but the degree of detachment varied. In some smears leukocytes were seen in the
epithelia and in the submucosa, but almost never in the lumen (Fig 3.5C). There
were very few gaps between epithelial cells. The cervix had relatively less
desquamed epithelial cells in the lumen than the vagina (Fig 3.5D).
3.2.4. Histology at metestrus
The stratum corneum was almost completely detached, but can be seen in the lumen
along with leukocytes in the tissues sections (Fig 3.6A). The outer epithelium
appeared to lose integrity and there was infiltration of leukocytes, which have darker
staining nuclei than the surrounding epithelial cells (Fig 3.6B). Individual
leukocytes were seen in the submucosa and basal layers of the epithelium and
aggregates of cells were observed in the superficial layers of the epithelium,
sometimes forming small foci. Some cells were identified as neutrophils based on
their distinctive multi-lobed nuclei (Fig 3.6C). The outer epithelia layers were
obviously disrupted in the majority of tissue sections and there were gaps between
epithelial cells. Leukocyte infiltration is not uniform throughout the lower
reproductive tract with some areas experiencing rapid infiltration and loss of
epithelial cell layers while other areas have slower infiltration and an extended
period of slow loss of the epithelial layers (Fig 3.6A-C). This makes early and late
metestrus difficult to differentiate. In this study metestrus is characterised as
beginning with the widespread loss of the stratum corneum and infiltration of
leukocytes and ends with extensive loss of deeper epithelial layers, decreasing
leukocytes in the epithelium and formation of the thick, dark outer epithelial layer
characteristic of diestrus (described below and in Fig 3.7A and C).
3.2.5. Histology at diestrus
The lumen was mostly cell free in tissue sections (Fig 3.7B) and the epithelia was
generally thin with only 2-3 cell layer present in some areas, though this varied
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within the FRT and even within a single field of view. The outer epithelium
contained leukocytes. In some places the leukocytes were in clumps in the
epithelium, but in others they were largely absent or only visible in the lumen.
While the epithelia appeared to be less leaky than in metestrus, they were less tightly
packed than in proestrus or estrus as there were visible gaps between the epithelial
cells (Fig 3.7B). Where the epithelium was thinnest the outer epithelium contained a
thicker solid band of cells (Fig 3.7A and C). The dark nuclear staining in the outer
epithelia implies that it was made up of leukocytes. The cervical epithelia were
generally slightly thinner than the vaginal epithelia. The cells contained large
vacuoles and there were large nucleated cells in the lumen (Fig 3.7D and E).
3.2.6. Histology of progesterone treated mice
The histology of the FRT after progesterone treatment was also characterised
because it will be used later in the study. B6.CD45.1 mice were injected
subcutaneously with 100 µl (30 mg/ml) Depo-Provera. 5 days later the FRTs were
removed and H& E stained. In all sections the epithelia were thin and all layers
contained nucleated cells (Fig 3.8A). Large mucus-filled vacuoles were seen in the
superficial layers of the epithelia (Fig 3.8C) and there were gaps in the basal layer of
the epithelium. Leukocytes, characterised by darker staining nuclei, were still
present under the mucified cell layer (Fig 3.8B). The cervical epithelia were
slightly thinner than the vaginal epithelia and there was more mucification of cells
(Fig 3.8C).
3.3. Discussion
During proestrus the epithelia thickens leading up to estrus, where ovulation occurs.
After ovulation the stratum corneum sloughs off in sheets. While the stratum
corneum desquames, the underlying epithelia integrity appear to remain intact as
there are no visible gaps between epithelial cells. At the very end of estrus
leukocytes begin to infiltrate into the tissue and appear in the epithelia. Widespread
leukocyte infiltration marks the end of estrus and the beginning of metestrus [67]. At
metestrus the squamous layers were less organised, probably due to the influx of
leukocytes. At diestrus the epithelia is thin and has a sticky thicker outer layer that
shows the beginning of mucification.
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High dose progesterone treatment is a common way of synchronising mice into
diestrus [50, 69]. The smears and tissue sections of diestrus and DP mice were
similar. After Depo-Provera treatment the superficial epithelial cells were more
heavily mucified than at diestrus, consistent with pseudopregnancy, which is
characterised by high progesterone levels causing mucification of the epithelium [67,
70].
The changes in architecture do not happen simultaneously throughout the tract.
Some areas can have characteristics of different estrous cycle stages to other areas. I
found no evidence of consistent variation up or across the tracts in the serial sections
of numerous mice; instead it is likely these differences are due to individual
differences in the geography of the vaginal epithelia and luminal fluid flow. This
leads to some, more exposed, areas sloughing faster than others and may lead to
variations hormone concentrations and cell recruitment in some areas.
The variation within the local environments of the tissue cannot be reflected in the
smears, which provide a rough sample of the outer epithelia and lumen of the lower
FRT. Vaginal smears provide an approximate overview of the tissue, but cannot, for
example, readily determine between an early estrus mouse with the SC only just
starting to desquame or a late estrus mouse with almost complete detachment of the
SC and infiltration of leukocytes into the basal epithelia, both of these smears would
consist exclusively of large cornified epithelial cells. Vaginal smears are indicative
of the state of the tissue, but will never provide the more comprehensive information
that serial tissue sectioning can.
Vaginal smears offer a quick and convenient method of determining estrous cycle
stage, however they are not always clear cut; it is possible to get transitional smears
that are difficult to assign to one stage or another. The rapid and substantial changes
in the vaginal epithelia mean that the outer epithelium is in constant flux. The
cellular composition of vaginal smears is very dynamic and while a 4 stage estrous
cycle seems superficially simpler to classify, it is a little crude and conceals a lot of
the subtle differences between the smears.
There is a great deal of variation between individual mice in the overall cellularity
and viscosity of the smears, which is difficult to factor in to a classification scheme.
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Vaginal smears are therefore a good indicator of estrous cycle stage and conditions
in the tissue, but it cannot be assumed that they are 100% accurate or that they reflect
every corner of the FRT.
Neutrophils are recruited into the vagina by the chemokine MIP-2, an IL-8
homologue [71] after the drop in estradiol after ovulation [72]. Epithelia cells can
produce inflammatory cytokines/chemokines, which recruit granulocytes from the
blood [40, 71, 73]. It is unknown whether neutrophils are responsible for the
disruption of the outer epithelia and the sloughing of the cell layers under the stratum
corneum or if neutrophil infiltration is a side effect of the loss of cells. It is possible
that the loss of the superficial layers of epithelium and invasion by bacteria/fungi
caused by the increased permeability of the epithelium may trigger stress responses
in epithelial cells. The barrier function of uterine epithelial cells has been shown to
be effected by hormonal changes [41] and it possible that changes in the vaginal
epithelial cell barrier may lead to the penetration of lumen contents into the epithelial
layer causing production of chemokines by epithelial cells.
Figure 3.1: Serum hormone concentrations in mice.
The hormones progesterone (blue) and estrogen (orange) fluctuate over the estrous
cycle. Estrogen peaks at estrus, when ovulation occurs, then drops off. Progesterone
increases after ovulation. Based on data from [74].
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Figure 3.2: Experimental Procedure.
1. Vaginal smears were taken from C57BL/6 or CD45.1 female mice and H&E
stained to determine cycle stage. 2. The FRTs were removed. 3. Sagittal view of
murine reproductive tract. 4. FRTs were split into cervix, upper vagina and lower
vagina (boxes) and snap frozen. 5. 7 µm serial transverse sections of tissue were cut
on a cryostat. 6. Diagram of transverse tissue section showing vaginal lumen in
centre, with epithelium and surrounding connective tissue.
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Figure 3.3: Vaginal Smears
A) Proestrus vaginal smear; insert shows a nucleated epithelial cell (arrow head) and
an anucleated epithelial cell (arrow) showing early cornification. B) Estrus vaginal
smear; insert shows cornified epithelial cells. C) Metestrus vaginal smear; insert
shows leukocytes (arrow) and cornified epithelial cell (arrow head). D) Diestrus
vaginal smear; insert shows leukocytes (arrow) and nucleated epithelial cells
(arrowhead). E) Vaginal smear from Depo-Provera treated mouse; insert shows
clumped leukocytes.
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Figure 3.4: Histology of lower FRT at proestrus.
H&E stained vaginal smears and 7 µm transverse sections of lower FRT tissue from
6-8 week old C57BL/6 or B6.CD45.1 female mice. A) x10 image of vagina. A-C)
Vagina at early proestrus. B) Early proestrus C) Late proestrus; insert shows the
outer epithelium. Ep epithelium, L lumen, SC stratum corneum, SM submucosa
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Figure 3.5: Histology of lower FRT at Estrus
H&E images of vaginal smear and 7 µm transverse sections of vagina and cervix at
estrus. A) Lower vagina with lumen containing epithelial cell sheets. B) Vagina at
early estrus. C) Vagina at late estrus; insert shows leukocytes in epithelium
(arrows). D) x10 image of upper vagina epithelium (right) and cervical epithelium
(left) showing the difference in the level of epithelial sloughing. Red arrows indicate
sloughed cornified epithelial cells. Ep epithelium, L lumen, SC stratum corneum,
SM submucosa.
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Figure 3.6: Histology of lower FRT at metestrus.
H&E images of 7 µm transverse sections of vagina at metestrus. A) Lower vagina
B) Vagina with leukocyte infiltration (arrows). C) Vaginal epithelium; insert shows a
close up of neutrophils. Arrows show leukocytes. Ep epithelia, L lumen, SM
submucosa.
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Figure 3.7: Histology of lower FRT at diestrus.
H&E images of 7 µm transverse sections of vagina and cervix at diestrus. A)
Vagina. B) Vagina at early diestrus with leukocyte infiltration (arrows). C) Vagina
at late diestrus; insert shows the epithelium. D) Cervix. E) Cervix showing
leukocytes in the epithelium and lumen (arrows) and nucleated epithelial cells in the
lumen (arrow heads) .Arrows show leukocytes. Ep epithelium, L lumen, SM
submucosa.
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Figure 3.8: Histology of lower FRT after high dose progesterone treatment.
CD45.1 female mice were treated with 100 µl Depo-Provera. 5 days later vaginal
smears were taken and H&E stained. FRTs were then frozen and 7 µm sections
were cut and stained with H&E. A) Vagina. B) Vagina showing thinned
epithelium. C) Vagina showing mucification of the outer epithelia. D) Cervix
showing mucification. Ep epithelium, L lumen, SM submucosa.
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4. Localisation of innate immune cells in the FRT
4.1. Introduction
Estrogen receptor expression is found both in lymphoid organs and bone marrow and
on DCs and macrophages [40]. Differential estrogen levels are thought to affect early
DC development by affecting the differentiation of DC precursors in the bone
marrow [58]. Estrogen has different effects on different DC development pathways,
promoting GM-CSF induced DC development pathways and inhibiting Flt-3L
mediated development pathways [58]. These studies show how systemic estrogen
may affect the immune system as a whole; however it does not highlight the
immediate effects of estrogen on cells within tissues. Macrophages, B cells and T
cells can all express progesterone receptors, although it is unclear whether this is
constitutive or induced as the data comes from pregnant women [21], which raises
the possibility that progesterone can have direct effects on immune cells.
The efficiency of intravaginal vaccination is affected by phase of the estrous cycle
[75, 76], a finding that might have significant implications on FRT vaccination
strategies. There is some evidence that susceptibility to infections in the FRT may
change over the estrous/menstrual cycle [59]. For example mice are more
susceptible to HSV-2 infection in metestrus and diestrus [50, 76], but are more
susceptible to Neisseria gonorrhoeae infection at proestrus [59]. Rhesus macaques
are more susceptible to SIV infection during the progesterone high stage of the
menstrual cycle, whereas estrogen is protective [21, 77]. Women show increased
susceptibility to HIV and other STIs while taking progesterone contraceptives [21,
77] and hormones have effects on susceptibility to candidiasis and Chlamydia [78] .
These differences could be due to a variety of factors. It may simply be the result of
epithelia thinning during progesterone high stages which allows easier access for
pathogens [21, 77], or changes in epithelium permeability [79]. Antibody and
antimicrobial peptide concentrations vary of the course of the estrous cycle, as do
chemokine levels [21, 59]. Estrogen inhibits expression of the chemokine MCP-1 by
stromal cells in the uterus [21]. Cyclic changes in the commensal bacteria,
particularly H2O2-producing Lactobacilli [21], that line the FRT [80] may affect
Characterisation of antigen-presenting cells in the murine female reproductive tract
and its draining lymph nodes
29
susceptibility to viral infections [77]. T cell and B cell populations in the FRT can
vary over the reproductive cycle, as does IgG and IgA production [21, 77].
Activation of T cells in the presence of progesterone inhibits Th1 responses and
promotes Th2 responses by inducing IL-4 production and inhibiting IL-12
production by APCs [21, 77] [59]. Estrogen has varied affects on immunity; it can
be both pro-inflammatory and have inhibitory affects. In rats, estradiol increases
antibody levels in the uterus, but reduces levels in the vagina [77]. Low doses of
estrogen are pro-inflammatory while high doses are anti-inflammatory [21].
In this chapter the distribution of DC and macrophage in the mouse FRT during
cycle will be compared to previously published studies.
4.2. Results
4.2.1. Dendritic cell and macrophage localisation in the FRT in
different hormonal conditions
The location of APCs within the tissue is important because it will affect their ability
to sample antigen from the lumen and to interact with other cells. To investigate
whether APC localization within the tissue is affected by the hormonal changes the
vaginas from estrus (the estrogen high stage), metestrus (the progesterone high stage
characterized by large infiltration of leukocytes) and progesterone treated mice were
stained for CD11c and CD68 (Fig 4.1).
There were greater numbers of CD11c+ cells in the submucosa compared to the
epithelia both at estrus and metestrus (Fig 4.1). At estrus only the basal layers of
epithelial cells were nucleated and stained DAPI+ (Fig 4.1A). The cornified sheets
of cells auto-fluoresced so can be seen adjacent to the lumen. CD11c+ cells were
almost completely absent. Despite the fact that the epithelium had increased in
thickness, CD11c+ cells were only present in the basal layer or immediately
underneath with processes reaching in between the epithelial cells. No CD11c+ cells
were observed reaching to the luminal edge of the epithelia. There were fewer cells
in the submucosa compared to metestrus. At metestrus CD11c+ interdigitating cells
(Fig 4.1C arrows) were present in both the basal and superficial layers of the
epithelium (Fig 4.1C).
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CD68+ cells were largely absent from the epithelia in both estrus and metestrus (Fig
4.1B and D). They were present throughout the submucosa at similar levels in both
estrus and metestrus. There were no obvious differences in CD68+ localisation
during cycle.
4.2.2. Localisation of CD11c and MHCII expressing cells throughout
the tract
To see if there are any differences in the distribution of APCs in the lower FRT serial
tissue sections from Depo-Provera treated mice were stained for the DC markers
CD11c and MHCII. Depo-Provera treated mice were used because they have
identical hormone conditions which mean that any variation between mice is not due
to them being in different estrous cycle stages. In order to effectively quantify cell
localisation pixel counting was compared with cell counting (Fig 4.2). There were
no significant differences between the two quantification methods.
There was more variation in cellularity between different mice than within one
mouse; some showed low cellularity (Fig 4.3A and B), while others showed high
cellularity (Fig 4.3C and D). There were no significant differences in the numbers of
CD11c+, MHCII+ or CD11c+MHCII+ cells in the epithelia of lower vagina compared
to the upper vagina/cervix (Fig 4.3E-G). There were no significant difference in the
numbers of CD11c+MHCII- and CD11c+MHCII+ cells in the epithelia (Fig 4.3E&G),
but very few MHCII+CD11c- cells in the epithelia (Fig 4.3F).
4.2.3. Localisation of CD68 and MHCII expressing cells throughout
the FRT
To compare macrophage cell numbers in the epithelia at different locations in the
lower FRT sections of FRT tissue from Depo-Provera treated mice were stained for
the tissue macrophage marker CD68 and a marker of antigen presenting capability
MHCII.
The majority of stained cells were in the submucosa with smaller numbers in the
epithelium (Fig 4.4A-D). There was no significant difference between the numbers
of CD68+, MHCII+ or CD68+MHCII+ in the epithelia of the lower vagina or upper
vagina and cervix (Fig 4.4E-G).
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4.2.4. Localisation of GR-1 and CD11c expressing cells in the FRT
In progesterone treated mice there is infiltration of neutrophils (Fig 3.8). To
investigate if this infiltration has any affect on DCs FRTs from progesterone treated
mice were stained for CD11c and a neutrophil/monocyte marker Gr-1.
GR-1+ staining was absent in tissue sections stained with the isotype control (data
not shown) and was also absent from tissue sections from the estrus stage (data not
shown). There was a great deal of variation within the tissue. There were areas of
very high GR-1 staining (Fig 4.5A and B) and areas of very low Gr-1 staining (Fig
4.5C and D) present within 1 tissue section. There was no significant difference in
the number of CD11c+ cells in the upper vs. lower tract or in the level of neutrophil
infiltration in the outer epithelia. There was no significant difference in the number
of CD11c+ cells in the areas where there were a lot of GR-1+ cells compared to areas
where there were fewer GR-1+ cells.
4.2.5. Immunohistochemistry versus flow cytometry for determining
cell localisation
In Figure 4.6A cells from the pooled, digested vaginal epithelium of mice in diestrus
was stained for CD11c vs. MHCII. 2 populations of CD11c+MHCII+ cells were
seen. Split populations like this cannot be detected using immunohistochemistry;
either because of the higher background fluorescence present in tissue sections (due
to mucus), which would mean low expression is not above the isotype control, or
because immunohistochemistry lacks the sensitivity to differentiate between low,
intermediate and high expressing cells.
Flow cytometry allows staining for more markers (Fig 4.6B and C), which gives a
more comprehensive charactersation of the cell populations present.
Immunohistochemistry, however, is superior for showing localisation of cells within
tissue. Cryopreservation and fixation of tissue is relatively unintrusive and the tissue
and the cells within it remain intact and in place. With flow cytometry the tissue is
processed into a single cell solution, so the validity of assumptions about localisation
depends on the ability to separate the epithelia from the underlying lamina propria.
This is done by manually scraping the epithelia off and using an enzyme mix to
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break the intercellular bonds. While this can be done to a certain level of accuracy
there is still a much higher chance of cells from the lamina propria becoming washed
onto the epithelium or vice versa. It is also lacks the subtlety to measure cells that
line the border between the basal layer of the epithelia and the submucosa, or cells
that reside in one but extend processes into the other as many of the CD11c+ cells in
the FRT do.
4.3. Discussion
The localisation populations of CD11c+ DCs, CD68+ macrophages and Gr-1+
neutrophils within the FRT of progesterone treated mice were examined. Mice from
the same estrous cycle stage could be used, however (as shown in chapter 3), cyclic
changes are not necessarily consistent throughout the tissue and vaginal smears are
not always clear cut. It is therefore better to use Depo-Provera treatment as a control
for cycle stage variation.
4.3.1. Hormonal effects on cell localisation
CD11c+ cells (predominantly DCs) are the main antigen presenting cell that are
responsible for initiating protective immune responses. There were increased
numbers of CD11c+ cells in the epithelia in metestrus and in progesterone treated
mice. This is consistent with published literature [81-83], which shows hormone
mediated changes in cell recruitment in the vagina. There were differences in
CD11c+ cell localisation in different hormonal conditions in the reproductive tract
(Fig 4.1), with estrus stage showing extremely low levels of CD11c+ cells in the
vaginal epithelia. There is evidence that the number of immune cells fluctuate in the
FRT over the estrous cycle [28, 82-84] and that this may affect immunity and
susceptibility to disease. The localisation and function of DCs and macrophages in
the FRT in rats and humans are affected by sex hormones [21, 56, 59, 81-83].
Langerhans’ cell (LC) numbers vary over the reproductive cycle [21, 83]. In mice,
the repertoire of DC subtypes also changes at different stages of the estrous cycle
[28].
In the gut DCs can reach out into the lumen from beneath the epithelial layer and
sample antigen [85-87] and during infection it has been observed that DCs in the
outer epithelia of the vagina also extend processes into the lumen [88]. At estrus no
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CD11c+ cells were observed reaching to the luminal edge of the epithelia, whereas at
metestrus CD11c+ cells were seen throughout the epithelial layers, similar to in the
skin, where LCs sit within the stratified cell layers of the epidermis [48, 49, 89]. It
appears that luminal antigen-sampling by CD11c+ cells does not occur at estrus,
which may have implications for antigen presentation and initiation of the immune
response.
CD68+ tissue macrophages are professional phagocytes that perform homeostatic
roles within the tissue , including clearance of apoptotic cells and would repair [90,
91]. Macrophages have a homeostatic role in uterus and ovary in humans [40].
Vaginal macrophages are phenotypically different to macrophages in other mucosal
sites [92] and peripheral blood [93]. CD68+ tissue macrophages can express MHCII
and present antigen to T cells [94] and can also influence the initiation of immune
responses by cross-talk with other APCs and T cells [90]. Macrophages express the
estrogen receptor and are responsive to progesterone, with macrophage numbers in
the endometrium fluctuating over the menstrual cycle [40]. No difference in CD68+
cell localisation was observed in the murine vagina under different hormonal
conditions, implying that there would be no difference in vaginal macrophage
antigen presentation during the estrous cycle.
4.3.2. Distribution of cells along the lower FRT
In humans immune cells are not distributed throughout the lower FRT uniformly.
DCs are most abundant in the cervix and other immune cells are clustered around the
cervical transformation zone, where the ecto- and endocervix meet, with very few
cells in the vagina [95]. Comparisons of the proximal and distal vagina have shown
some differences in T cell distribution [95]. Differences in cell localization and
numbers along the tract may affect immunity. Different pathogens invade the FRT
at different locations. For example, the vagina is prone to Candida albicans and
Trichomonas vaginalis infection, the cervix is prone to Chlamydia trachomatis and
Neisseria gonorrhoea infection and HPV preferentially infects the transformation
zone [28, 47, 95].
There was variation in the localisation of macrophages, DCs and, neutrophils in the
FRTs of progesterone treated mice (Fig 4.3 and 4.4), leading to lots of distinct
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microenvironments along the length of the lower reproductive tract. However, no
statistically significant pattern was observed, that would account for the consistent
differences in susceptibility to infection described above.
4.3.3. Affects of neutrophils on APCs
Neutrophils enter the FRT from the blood in response to IL-8 and other chemokines
produced by epithelial cells [40]. Infection and insemination results in increased
neutrophil recruitment to the FRT in humans [40]. In humans rapid neutrophil
recruitment in response to stimuli is particularly associated with the cervix [40]. In
the human uterus falling progesterone levels triggers an increase in IL-8 production
by uterine epithelial cells [40].
The high progesterone stages of estrous cycle are characterized by physiological
infiltration of leukocytes, the majority of which are neutrophils (Fig 3.3, 6 and 7)
[40, 82]. GR-1 is expressed in high levels on neutrophils, although, it is also
expressed by plasmacytoid DCs and some monocytes [96]. There was variation in
the density of GR-1+ staining in the FRTs of progesterone treated mice (Fig 4.5),
however no pattern in distribution of GR-1+ cells in different areas of the lower FRT
were observed. The differences are most likely due to variations in the
microenvironments over the epithelium caused by the normal undulations in the
tissue.
Neutrophils have been shown to effect APC recruitment and function and may
interact directly with APCs [25, 97-101]. To investigate the affect of neutrophil
infiltration to the epithelia on CD11c+ cell localization in the epithelia tissue sections
from the vaginas and cervixes of Depo-Provera treated mice were stained for Gr-1
and CD11c. There was no significant difference in the number of CD11c+ cells in
the areas where there were a lot of GR-1+ cells compared to areas where there were
fewer GR-1+ cells. This does not exclude the possibility that GR-1+ cells were
responsible for recruitment of CD11c+ cells (Gr-1+ cells were present in all sections
with CD11c+ cells), but shows that increasing numbers of GR-1+ cells did not cause
a proportional increase in CD11c+ cells. There was no correlation between different
density of GR-1+ staining and CD11c+ staining. This shows that while hormonal
changes mediate changes in neutrophil infiltration (Fig 3.6-8), the frequency of
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neutrophils does not affect DC localisation in the epithelia. This does not rule out
the possibility that the presence of neutrophils may affect DC localisation; just that it
is not ‘dose dependant.’
4.3.4. Quantification of confocal images
While no significant differences in the 2 quantification methods were seen, there are
still issues with cell counts and pixel counts. Due to the changes in the epithelia
thickness measurement of cells per unit area and pixel counts expressed as a
percentage of total pixels (essentially an expression of area) are flawed. For example
if the cell numbers in the epithelia remain the same but the epithelia thickens this
analysis would show a reduction in cells/mm2 despite unchanging cell numbers.
Measuring the length of the epithelium along the basal edge, which remains
relatively unchanged over the estrous cycle (as opposed to measuring the length of
the luminal edge of the epithelium, which becomes disrupted), allows for a more
accurate prediction of the relative number of cells at different locations and at
different cycle stages. Pixel counts cannot discriminate between the same number of
cells with greater surface expression and therefore more staining and increased
numbers of cells expressing similar levels of surface protein. Both of these scenarios
would result in an increased pixel count.
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Figure 4.1: Comparison of DC and macrophage localisation within the epithelia
of the FRT at different stages of the estrous cycle.
7 µm sections from CD45.1 or C57BL6 mice were stained for CD11c or CD68
(green) and DAPI (blue). Images are representative of 3-6 images per mouse.
Estrous cycle stage was determined by H&E staining of tissue sections. A) CD11c
stained vagina at estrous. B) CD68 stained vagina at estrus. C) CD11c stained vagina
at metestrus D) CD68 stained vagina at metestrus. White arrows show positively
stained cells. Ep. Epithelia L. Lumen SM. Submucosa.
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Figure 4.2: Pixel count versus cell count analysis.
A) For pixel counts the analysis was done in Photoshop. A line was drawn around
the epithelium and then the epithelium was selected. A total pixel count for the
epithelium was performed followed by selected counts on the green, red and yellow
channels in turn. B) The epithelium was then excluded and the submucosa selected.
Total pixel counts for the submucosa and for each individual channels was
performed. C) For cell counts the length of the basal layer of the epithelia was
drawn using the LSM image browser software. D) Cell counts were performed using
ImageJ software. E) For the total CD11c counts the red and yellow channels were
added together and expressed as a percentage of total pixels for each field of view.
Percent pixel values from 3-6 fields of view were averaged to give a single point for
the lower and upper vagina for each mouse. F) Cell counts were expressed as
cells/mm. Each point represents the average cells/mm from 3-5 fields of view. G)
To compare the 2 methods of quantification cells/mm was plotted by % total pixels.
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Figure 4.3: Comparison of CD11c+ cells in the epithelia and sub mucosa of the
vagina and upper vagina/cervix of Depo-Provera treated mice.
4 female CD45.1 mice were injected subcutaneously with 100 µl of 30 mg/ml Depo-
Provera. 5 days later reproductive tracts were removed and 7 µm sections were cut,
then stained for CD11c (red), MHCII (green) and DAPI (blue). Representative
images of the lower vagina (A and C) and upper vagina/cervix (B and D) of 2
individual mice. A) and B) Mouse with comparatively low numbers of cells in the
FRT. C) and D) Mouse with comparatively high numbers of cells in the FRT. (E-G)
Average cells/mm CD11c single positive (E), MHCII single positive (F) and CD11c
and MHCII double positive (G) cells per mouse. Images are representative of 3-6
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images lower vagina and 3-6 images per upper vagina/cervix from 4 different mice.
Ep epithelia, L lumen, SM submucosa
Figure 4.4: CD68 and MHCII positive cells in the epithelia of Depo-Provera
treated mice.
Vaginas from 4 B6.CD45.1 mice treated with 100 µl 30 mg/ml Depo-Provera were
cut into 7 µm tissue sections. A-D) Representative images of CD68 (red), MHCII
(green) and DAPI (blue) stained sections of upper and lower vagina. E-G)
Comparison of the average number of CD68+, MHCII+ and CD68+MHCII+ double
positive cells per mm in the epithelia of the upper and lower vagina. Images are
representative of ≥5 images per group from 4 different mice.  Ep epithelia, L lumen, 
SM submucosa
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Figure 4.5: DCs and neutrophils in the vagina and cervix of Depo-Provera
treated mice.
The vagina and cervix of 4 Depo-Provera treated B6.CD45.1 mice were isolated and
7 μm tissue sections were counterstained with DAPI (blue) and stained with Gr-1 
(red) and CD11c (green). A-D) Images are split into from top left to bottom right -
blue only, red only, green only and merged image. A) and B) Vagina and cervix of 1
mouse. C) and D) Vagina and cervix of a 2nd mouse. E) CD11c+ cell and Gr-1+ cell
interacting within the epithelia. F) Higher magnification z stack image of E). G)
CD11c+ cells numbers in the epithelia of upper and lower vagina. The graph
compares DC numbers in areas of high neutrophil density (A and B) and low
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neutrophil density (C and D). Each point represents one field of view. Images are
representative of ≥3 images per group from 4 different mice. Ep epithelia, L lumen, 
SM submucosa
Figure 4.6 Diverse phenotypes of CD11c+MHCII+ cells from the vaginal
epithelia.
C57BL/6 female mice. Dead cells were excluded using a live/dead discriminator.
Live cells were selected based on forward scatter vs. side scatter. Haematopoietic
cells were selected based on CD45.2 expression. A) CD11c vs. MHCII expression
in CD45.2+ cells. B) F4/80 vs. CD11b expression in CD45.2+CD11chiMHCII+ cells.
C) F4/80 vs. CD11b expression of CD45.2+CD11cloMHCII+ cells.
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5. Characterisation of the lymph nodes draining the
reproductive tract
5.1. Introduction
The immune system at mucosal sites is considered to be linked, because of the
preferential trafficking of T cells primed in mucosal dLNs to other mucosal
lymphoid tissues rather than to the spleen or peripheral LNs [102, 103]. This means
that immune responses primed at one mucosal site can elicit protective immunity at
distal mucosal sites.
Mucosal lymph nodes have a different ontogeny to other peripheral LNs and are the
first secondary LNs to develop in the embryo [104]. In most cases, mesenchymal
cells initiate LN development by production of CXCL13, which binds CXCR5 on
LTi precursor cells. LTβ signalling between mesenchymal cells and LTi cells causes
differentiation of the mesenchymal cells into stromal organiser cells, which give rise
to the LN stromal cell populations (MRCs, FRCs etc) [104, 105]. Hence, mice
deficient in CXCR5 and CXCL13 lack iliac LNs and other peripheral LNs [106] and
LTβ deficient mice lack most peripheral LNs and Peyer’s Patches [69, 104, 107, 
108]. Surprisingly, MLNs and CLNs are found in mice lacking CXCR5 and
CXCL13 [106].  Similarly, MLNs, CLNs and ILNs are present in LTβ deficient mice 
[69, 104, 107, 108]. These findings imply that mucosal LNs associated with the
airways and gut are fundamentally different to other secondary lymphoid tissues.
Lymph nodes function as local hubs for interactions between immune cells. Antigen
presentation to naïve T cells as well as T-B cell interactions, which lead to initiation
of the cellular and humoural adaptive response, occur here [28, 36, 44, 109-116].
The environment in draining lymph nodes can affect T cell responses [44, 112].
Upon activation naïve T cells change their expression of surface adhesion molecules,
which allows them to exit the LN via the lymphatic vessels. The environment
produced by APCs and stromal cells in LNs induces expression of different adhesion
molecules on T cells [36, 44, 117]. The endothelial cells in different mucosal tissues
and lymph nodes express different adhesion molecules meaning that only certain
subsets of T cells can enter [69, 71, 84, 118]. For example, MLN stromal cells
Characterisation of antigen-presenting cells in the murine female reproductive tract
and its draining lymph nodes
43
produce retinoic acid (RA), which promotes gut-homing by inducing expression of
the mucosal addressin MAdCAM-1 [36-38, 44, 114]. Lymph node stromal cells
have also been shown to present antigen [119]. There are variations in LN stromal
cells in different LNs [36-38], which means that there may be LN specific
differences in antigen presentation intrinsic to the stromal cells. In this chapter, the
architecture and cellular composition of LNs draining the FRT were compared with
other mucosal (mesenteric and cervical) and skin draining LNs.
5.2. Results
5.2.1. Iliac lymph nodes are architecturally similar to other mucosal
lymph nodes
While lymph node architecture has been well characterised [34, 114, 115, 120] there
has been little comparison of different lymph nodes. Differences in architecture of
the LNs especially the locations of APCs and T cells may point to differences in
antigen-presentation and subsequent immune responses. Therefore, the
macrostructure of the cervical, mesenteric and iliac lymph nodes were compared.
Mice expressing a variety of fluorochromes under the control of cell-specific
promoters/locus control regions allow visualisation of lymph nodes in steady state
without the need to treat with injectable markers.
CD19CreR26REYFPVaDsRedxC57xC57 mice, which express EYFP in CD19
positive cells and DsRed in CD2 positive cells, were dissected on a fluorescent
stereo microscope to show the locations of cervical, mesenteric and iliac lymph
nodes (Fig 5.1B). Lymph nodes have discreet T cell (depicted blue after image
analysis) and B cell (green) zones. There were differences in size of lymph nodes
with MLNs being largest. The superficial cervical lymph nodes are also relatively
large with smaller deep cervical LNs. Iliac lymph nodes are small and are slightly
inconsistent in location (data not shown). They are sometimes both on one side of
the aorta and sometimes on both sides, but are always just above the base of the
spine. It is unknown if this variability could affect immune responses in different
animals.
Sections of frozen iliac, mesenteric and cervical lymph nodes from naïve C57BL/6
mice were stained with markers for DCs (CD11c+, MHCII+), B cells (MHCII+),
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marginal reticular cells (gp38+) and lymphatic (CD31+, gp38+) and vascular
endothelial cells (CD31+). Fig 5.2 shows representative images of ILNs, CLNs and
MLNs. MHCII +CD11c- B cells are situated in the cortex in defined follicles.
CD11c+ DCs are located in the medulla and surround the B cell follicles but are
rarely seen within the B cell follicles. CD31+gp38- HEVs are located in the medulla.
The gp38+ MRCs form structural support for the T cell zones and subcapsular sinus
(SCS) [34, 117]. The localisation of CD11c+ cells around CD31+ vessels, in the T
zone and around B cell follicles were comparable, as was the number of B cell
follicles (Fig 5.2).
5.2.2. Iliac lymph nodes have comparable antigen-presenting cell
subpopulations to cervical lymph nodes, but not mesenteric lymph
nodes
Differences in DC numbers and phenotypes in the LN can affect downstream
immune responses. The DC populations in iliac LNs were characterised by their
expression of surface markers and compared with other mucosal and peripheral LNs.
LNs from Depo-Provera treated mice were pooled into groups of cervical lymph
nodes, iliac lymph nodes, mesenteric lymph nodes and a group of ‘other’ lymph
nodes, which included axillary and inguinal lymph nodes and then stained for
CD11c, MHCII, CD103 and CD11b.
CD11c and MHCII double positive cells were split into 2 subpopulations:
CD11chiMHCII+ and CD11c+MHCIIhi cells (Fig 5.3C) [121, 122]. The percentage
of DCs was consistently low, with total CD11chiMHCII+ and CD11c+MHCIIhi cells
accounting for less than 1.5% of total live LN cells in all lymph nodes. Comparison
of different lymph nodes showed different percentages of CD11chiMHCII+ and
CD11c+MHCIIhi cells (Fig 3C and D). Iliac lymph nodes had a much lower
percentage of both APC populations compared to other lymph nodes.
Both Iliac LNs and mesenteric LNs had lower percentages of CD11chiMHCII+
antigen presenting cells compared to cervical LNs and the pool of other lymph
nodes. Based on their CD103 and CD11b expression DCs could be split into 3
subpopulations (Fig 5.3C): CD103loCD11b+ cells, CD103+CD11b+ cells and
CD103+CD11b- cells. In all lymph nodes CD103loCD11b+ cells were the largest
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population. Percentages of CD103loCD11b+, CD103hiCD11bhi and CD103hiCD11blo
subtypes of CD11chiMHCII+ and CD11c+MHCIIhi cells were similar in CLNs, ILNs
and other LNs, but MLNs show higher CD103hiCD11bhi and CD103hiCD11blo cells.
In ILNs, CLNs and OLNs CD103loCD11b+ cells dominated. In the MLNs there
were similar percentages of all 3 subtypes with a roughly 3-fold increase in the
CD103+ subsets.
5.2.3. Comparatively low RALDH expression in iliac lymph nodes
To compare RALDH expression of both haematopoietic and non-haematopoietic
cells in cervical and iliac lymph nodes pooled LN cells from 5 Depo-Provera treated
C57BL6 mice each were stained for RALDH expression and surface molecules.
There were almost no detectable RALDH+CD45.1- non-haematopoietic cells in any
LNs (Fig 5.4B). The highest found was 0.7% of the CD45.1- population (or 21
cells), which is below the reliable detection of this assay. Iliac lymph nodes had the
lowest percentage of RALDH+CD45.1+ cells with roughly equal numbers in the
CLNs and ‘other’ LNs. A lower percentage of iliac lymph node CD45.2+ cells
showed RALDH activity compared to cervical lymph nodes. Fewer iliac lymph
node CD11c+MHCII+ cells show RALDH activity compared to cervical lymph node
cells.
5.3. Discussion
The FRT is a mucosal tissue, however in the lower FRT the epithelia and the
resident immune cells bear similarities to the skin. To determine if the FRT dLNs
were more similar to mucosal LNs or peripheral LNs that drain the skin, the iliac
LNs were compared to other LNs.
Iliac LNs are architecturally similar to MLNs and CLNs. ILNs have a lower
percentage of CD11c+MHCII+ APCs than MLNs or CLNs, even after accounting for
the lower total cell numbers (Fig 5.3). Different ratios or numbers of DC subtypes
may imply that there are functional differences between lymph nodes.CD11c+ DCs
in both the tissues and lymph nodes can be divided into functionally different
subtypes based on the expression of surface molecules. DC subtypes have been well
characterised in many other tissues [26, 50, 110, 112, 113, 123-128]. In the lungs
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CD11c+MHCIIhi cells, but not CD11chiMHCII+ have been shown to be responsible
for antigen transport to the dLN [122]. CD11c+MHCIIhi cells are thought to be
migratory DCs while CD11chiMHCII+ cells are LN resident DCs [128]. CD103+
DCs have been best characterised in the gut [85, 110, 129], but are also found in
other lymph nodes [113, 130]. CD103 expression is involved in attachment to
mucosal epithelial cells and is found in migratory DCs from mucosal lymph nodes
[85, 110, 131]. They have been shown to promote tolerogenic responses and effector
T cell homing to mucosal tissues [110, 129, 131]. ILNs have similar APC
populations to CLNs, but not MLNs.
The vitamin A metabolite retinoic acid (RA) is linked to oral tolerance because it can
affect T cell maturation by promoting the differentiation of Tregs and gut homing
[37, 113]. Retinal is converted to RA by RALDH enzyme activity [132]. In the
MLNs tissue-derived DCs and macrophages [133], as well as lymph-node resident
non-haematopoietic stromal cells [36-38], express RALDH and are thought to be
important for oral tolerance induction [37, 38, 114]. RALDH expression is
associated with the induction of gut-homing T and B cells and tolerance [37, 38, 113,
133, 134]. RALDH is also expressed by CD11c+MHCII+ cells in other mucosal
lymph nodes such as the mediastinal LNs that drain the lung, but is expressed at
much lower levels in skin-draining LNs and in the spleen [113]. In this study
RALDH expression in iliac LNs was measured and compared to other LNs, which
has not been investigated before. While RALDH expression was lower in iliac LNs
compared to other peripheral LNs, there is some evidence that RA may be important
in immunity in the FRT because there is increased HIV shedding in women with
vitamin A deficiencies [60].
The lower RALDH expression and lower DC ratios implies that ILNs are dissimilar
to other mucosal LNs. These differences in APC populations and the environment
within the ILNs potentially means that antigen presentation and the subsequent
immune response and long term immunity initiated will be different to the immune
responses initiated with the same antigen at a different mucosal site. This has
implications for treatment and prevention of STIs and for vaccination strategies
administered intravaginally or for vaccines that need to induce immunity in the FRT,
but are administered at different sites.
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Figure 5.1: Location of mucosal lymph nodes in mice.
A) Nomenclature of lymph nodes in mice, from [120]. B)
CD19CreR26REYFPVaDsRedxC57xC57 mouse was imaged. Blue colouration
shows T cells and green shows B cells. Arrows show trachea (red), small intestine
(yellow), colon (blue) and uterine horns (white). The zoomed images are separate
higher magnification images. Data is representative of 2 mice.
1. Mandibular LN
2. Accessory mandicular LN
3. Superficial parotid LN
4. Cranial deep cervical LN
5. Proper axillary LN
6. Accessory axillary LN
7. Subiliac LN
8. Sciatic LN
9. Popliteal LN
10. Cranial mediastinal LN
11. Tracheobronchal LN
12. Caudal mediastinal LN
13. Gastric LN
14. Pancreaticoduodenal LN
15. Jejunal LN
16. Colic LN
17. Caudal mesenteric LN
18. Renal LN
19. Lumbar aortic LN
20. Lateral iliac LN
21. Medial iliac LN
22. External iliac
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Figure 5.2: Architecture of mucosal lymph nodes.
3 C57BL/6 mice were injected subcutaneously with 100 µl 30 mg/ml Depo-Provera.
5 days later estrous cycle arrest was confirmed by vaginal washes. Lymph nodes
were removed and frozen in OCT.  8 μm sections were cut on a cryostat and then 
stained for MHCII (blue), gp38 (green), CD31 (yellow) and CD11c (red). Dashed
lines show B cell follicles. Yellow arrows show HEVs. Overlapping images were
taken on a confocal microscope and stitched together using Fiji software.
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Figure 5.3: Comparison of DC subtypes in iliac, mucosal and peripheral lymph
nodes.
Lymph nodes from 5 female Depo-Provera treated C57BL/6 mice were pooled and
stained for surface markers. A) Gating strategy. Live cells are selected based on
forward scatter vs. side scatter. Doublet discrimination based on pulse width vs.
forward scatter. Both CD11chiMHCII+ and CD11c+MHCIIhi antigen presenting cells
are analysed. B) Isotype control. C) CD103 and CD11b expression of
CD11chiMHCII+ and CD11c+MHCIIhi antigen presenting cells. D) % of total cells
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that are CD11chiMHCII+ and CD11c+MHCIIhi in different lymph nodes. E) % of
total gate of 3 subpopulations of CD11bCD103 expressing cells. 1) CD11chiMHCII+
2) CD11c+MHCIIhi i) CD103loCD11b+ ii) CD103hiCD11bhi iii) CD103hiCD11blo
Figure 5.4: RALDH expression in iliac and peripheral lymph nodes.
LNs from 5 female Depo-Provera treated mice were pooled into groups of CLNs,
ILNs and OLNs and stained for CD45.2 and with ALDEFLUOR for RALDH
activity. A) Gating strategy. Cells were gated on based on forward scatter vs. side
scatter. Doublets were excluded based on pulse width vs. forward scatter and dead
cells were excluded based on positive staining for the live/dead cell marker. B)
Cells were assessed for RALDH activity with or without the DEAB inhibitors.
DEAB inhibitors prevent RALDH activity. C) RALDH+ cells as a percentage of
total cells.
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6. Discussion
6.1. General conclusions
The FRT undergoes drastic changes over the reproductive cycle. In progesterone
high stages there is a large influx of leukocytes. The distribution of APCs is
constant along the length of the vagina and cervix. The numbers of Gr-1+ cells
varies greatly over the course of the reproductive cycle. The distribution of Gr-1+
cells within the tissue varies, with some areas showing relatively high numbers of
neutrophils in the outer epithelia and some areas showing much lower infiltration.
This study found no significant pattern to the areas of low or high neutrophil influx.
It is possible that this represents individual differences in the architecture of the
epithelia caused by differences in epithelial folding, thickness and mucus flow. This
shows that the frequency of APCs is constant throughout the tract, but that the local
environments within the tract may have differences in antigen capture and
presentation. There is a lot of variation along the length of the lower reproductive
tract and between mice, which may affect the design of future experiments. For
example more mice may be needed to get statistically significant results.
There is some evidence that neutrophils in the human fallopian tube [40, 135] are
phenotypically different to normal blood neutrophils. In mice anti-Gr-1+ cell
depletion results in estrous cycle arrest [136], implying a physiological role for
neutrophils. However, monocytes also express Gr-1 and depletion with the
neutrophil specific anti-Ly6G antibodies does not result in estrous cycle arrest
(Schäfer unpublished observations). It is not known if neutrophils recruited to the
vagina in the murine estrous cycle are different to blood neutrophils. There is a
rapidly growing literature on newly characterised neutrophil phenotypes and
functions [25, 97-101, 135]. This has led to a growing appreciation that neutrophils
are not merely rapidly recruited killer cells, but may have varied roles in the immune
response. [99, 137]
Iliac lymph nodes are architecturally similar to mesenteric and cervical nodes in
normal mice, as judged by distribution of B cell follicles, vascular and lymph
endothelia and DC localisation. Hence, there is unlikely to be any major differences
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in the cellular organisation or trafficking between iliac and other mucosal lymph
nodes. This does not exclude the possibility of differences in architecture occurring
during an immune response or as a result of cyclic changes.
The lymph nodes draining the FRT have a lower percentage of APCs compared to
other mucosal lymph nodes. APC’s can be divided into subpopulations based on
their expression of the surface molecules CD103 and CD11b. The ratios of different
subpopulations in FRT dLNs are comparable to cervical lymph nodes, but are
different to MLN ratios. In MLNs there are higher percentages of the CD103hi
subtypes. CD103 is involved in binding to epithelial cells so CD103 expression is
associated with cells that have migrated from the epithelia of mucosal tissues [138].
This implies that there are either fewer migratory DCs coming from the FRT and
nasal tissue or that CD103+ represent only a minor subpopulation of the migratory
DCs from these sites.
RALDH expression is lower in iliac LNs compared to cervical and other peripheral
LNs. Low RALDH expression implies a bias away from tolerogenic responses and
trafficking to mucosal tissues. However, tolerogenic responses in the skin are
associated with increased vitamin D metabolites and not RA [134], so it is possible
that vitamin D could induce tolerogenic responses in the FRT. Vitamin A deficiency
is associated with susceptibility to HIV infection [60], but the implication of this is
unclear. One possibility is that T cells primed in mucosal lymph nodes do not traffic
to mucosal tissues because they have not upregulated MAdCAM-1 and would traffic
to other LNs.
DCs represent a lower percentage of iliac LNs than in other LNs, this could mean
that the FRT has a lower potential for stimulating immune responses. This may be
due to either or both lower LN resident DCs and lower migratory DCs. Since the
ratios of DC subpopulations are equivalent to other lymph nodes, the data in this
study would imply an overall drop in DC numbers rather than changes in specific
subpopulations. If antigen presentation is equivalent in ILNs this could mean that
another cell type is providing antigen presentation, for example macrophages.
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6.2. Disadvantages of Mouse Models
The observation of a large infiltration of neutrophils during metestrus/diestrus and in
progesterone treated animals raises questions about the appropriateness of this model
to study human FRT biology. Neutrophils are not seen in large numbers in humans
either during the normal menstrual cycle or after hormone contraceptive treatment
[40]. There is no increase in neutrophils during the progesterone high stage of the
menstrual cycle despite increases in neutrophils chemoattractants [40, 139].
Mouse models have advantages over doing work on humans or macaques. Firstly,
there are lower ethical restraints. Secondly, there is a greater potential for genetic
manipulation due to the diverse genetic models in mice. Whilst not exactly the same
as humans, mice provide a good model for proof of concept studies.
An alternative would be to use in vitro experiments based on human FRT cell lines
or explants. Due to the high turnover of immune cells coming into the tissue from
the blood and that many of the important immunological events take place in the
lymph node, these methods come with a lot of caveats and cannot effectively mimic
complex inter-system interactions involved in immunity.
6.3. Future Work
Phenotyping of the neutrophils of the lower FRT and comparison with both blood
and uterine neutrophils would shed some light onto the homeostatic function of
neutrophils. It would also be interesting to compare the early events in primary
infection with or without neutrophils present to see if they have any effect on APCs
or the initiation of the adaptive immune response.
There is some evidence that macrophages in the human FRT are phenotypically
different to other macrophages [92] and it would be interesting to see what
differences this would have on immunity and if similar differences were also
observed in mouse models. FRT DC phenotypes have been more thoroughly studied
in mice [81].
‘Mucosalness’ of LNs is difficult to define. Immune responses to administered
antigen may prove a better way of comparing mucosal lymph nodes. It would be
important to study the trafficking of T cells primed in the FRT and their expression
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of MAdCAM-1 and other tissue addressins. This would have important implications
for systemic immunity and vaccine design. The data produced here provides a
foundation for such studies.
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Abbreviations
AIDS acquired immunodeficiency syndrome
APC antigen-presenting cell
APC allophycocyanin (Materials and Methods only)
BSA bovine serum albumin
CLN cervical lymph node
Cy cyanin
DAPI 4',6'-diamidino-2-phenylindole
DC dendritic cell
DEAB diethylaminobenzaldehyde
dLN draining lymph node
FACS fluorescence-activated cell sorting
FCS Foetal calf serum
Flt-3L fms-like tyrosine kinase-3 ligand
FRC fibroblastic reticular cell
FRT female reproductive tract
FSH follicle-stimulating hormone
gp38 podoplanin
GM-CSF granulocyte-macrophage colony stimulating factor
Gr-1 granulocyte differentiation antigen 1
H&E haematoxylin and eosin
HEV high endothelial venule
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HIV human immunodeficiency virus
HPV human papilloma virus
HSV herpes simplex virus
IL interleukin
ILN iliac lymph node
LC Langerhans’ cells
LH luteinizing hormone
LN lymph node
LPS lipopolysaccharide
LT lymphotoxin
LTi lymphoid tissue inducer
MAdCAM-1 mucosal addressin cell adhesion molecule-1
MCP-1 monocyte chemoattractant protein -1
MHCII major histocompatibility complex type two
MIP-2 macrophage inflammatory protein 2
MLN mesenteric lymph node
MRC marginal reticular cell
OCT optimal cutting temperature
OLN ‘other’ (mixture of axillary and inguinal) lymph nodes
PAMP pathogen-associated molecular pattern
PBS phosphate buffered saline
PE phycoerythrin
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PerCP peridinin chlorophyll A protein
PFA paraformaldehyde
PP Peyer’s patch
PRR pathogen-recognition receptor
RA retinoic acid
RALDH retinaldehyde dehydrogenase
SC stratum corneum
SCS subcapsular sinus
STI sexually transmitted infection
TGF transforming growth factor
Th1 type 1 helper T cell
TLR toll-like receptor
Treg regulatory helper T cell
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